Veristat and AOBiome Establish a Preferred Partnership To Support Ongoing & Impending...
SOUTHBOROUGH, MA – June 19, 2017 – Veristat, a full service Clinical Research Organization (CRO), announced today that Veristat and AOBiome,
Veristat Congratulates TESARO on the FDA Approval of ZEJULA™
SOUTHBOROUGH, MA – May 30, 2017 – Veristat, a full service Clinical Research Organization (CRO), congratulates TESARO, Inc. on the...
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive...
Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts
Veristat Opens New Office in North Carolina Today
Veristat announced today the official opening of its new office in Morrisville, NC.
Veristat Appoints James Roach, MD as Chief Medical Officer
Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings
SOUTHBOROUGH, MA – November 07, 2016 – Veristat...Veristat Formalizes its Strategic Decision Consulting Services
SOUTHBOROUGH, MA – November 01, 2016 – Veristat, a full-service consultative Clinical Research Organization (CRO), announced today the...
Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals
Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a Preferred Provider Agreement (PPA) with ...
Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s...
Veristat Continues To Be Recognized for Its Positive Impact & Company Growth
SOUTHBOROUGH, MA – August 17, 2016 – Veristat announced today...
Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in...
Two of Veristat’s statistical and adaptive design experts submitted a research paper which was published in the June 2016 issue of the ...